Management of Pregnancy-Related Nausea and Vomiting
Understanding Nausea and Vomiting in Pregnancy (NVP)
- NVP affects 30-90% of pregnancies, typically beginning at 4-6 weeks, peaking at 8-12 weeks, and subsiding by week 20 1, 2
- NVP is associated with elevated human chorionic gonadotropin and estrogen levels, as well as changes in GI motility due to progesterone effects 1
- Severity can be assessed using the Motherisk Pregnancy Unique Quantification of Emesis (PUQE) score, which categorizes symptoms as mild (≤6), moderate (7-12), or severe (≥13) 1, 2
Treatment Algorithm for NVP
- Identify and avoid specific food triggers and strong odors 1
- Consume small, frequent, bland meals (e.g., BRAT diet - bananas, rice, applesauce, toast) 1
- Focus on high-protein, low-fat meals 2
- For persistent symptoms, Diclegis (doxylamine-pyridoxine) is FDA-approved and recommended by ACOG as first-line therapy 1, 2
- Available in 10 mg/10 mg delayed-release combination tablets 1
Treatment for Refractory Cases
- For moderate-severe cases not responding to Diclegis, consider Metoclopramide (shown to have similar efficacy to promethazine with fewer side effects) 3
- Ondansetron (for severe NVP requiring hospitalization, but use with caution before 10 weeks gestation) 3
- Methylprednisolone (as last resort for severe hyperemesis gravidarum) 3, 4
Special Considerations
- Early intervention with appropriate treatment may prevent progression to hyperemesis gravidarum 1, 5
- Vitamin B1 (thiamine) supplementation (100 mg daily for 7 days, then 50 mg maintenance) should be considered in severe cases to prevent Wernicke encephalopathy 3
- For patients with severe symptoms, hospitalization for IV hydration and electrolyte replacement may be necessary 4
Monitoring
- Use the PUQE score to assess symptom severity and treatment response 1, 2
- Monitor for signs of dehydration, weight loss, and electrolyte imbalances in moderate-severe cases 4
- Assess for neurologic symptoms that might indicate vitamin deficiencies 3